StockNews.com initiated coverage on shares of Global Cord Blood (NYSE:CO – Free Report) in a report published on Monday. The firm issued a strong-buy rating on the medical research company’s stock.
Global Cord Blood Price Performance
Shares of NYSE:CO opened at $1.25 on Monday. The company has a market capitalization of $151.94 million, a price-to-earnings ratio of 1.95 and a beta of 0.16. The firm’s 50 day simple moving average is $1.57 and its 200 day simple moving average is $1.38. Global Cord Blood has a fifty-two week low of $2.03 and a fifty-two week high of $5.50.
About Global Cord Blood
Recommended Stories
- Five stocks we like better than Global Cord Blood
- Investing In Automotive Stocks
- Chinese Stocks Cool Off: Time to Buy the Dip in These 2 Stocks?
- Want to Profit on the Downtrend? Downtrends, Explained.
- Goldman Sachs Highlights 3 Top Short Squeeze Stocks to Watch
- How to Evaluate a Stock Before BuyingÂ
- Walmart is Up 56% YTD, Is it Still a Top Consumer Staples Stock?
Receive News & Ratings for Global Cord Blood Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Cord Blood and related companies with MarketBeat.com's FREE daily email newsletter.